Diagnosis and treatment of multiple sclerosis: a review

MP McGinley, CH Goldschmidt, AD Rae-Grant - Jama, 2021 - jamanetwork.com
Importance Multiple sclerosis (MS) is an autoimmune-mediated neurodegenerative disease
of the central nervous system characterized by inflammatory demyelination with axonal …

[PDF][PDF] Multiple sclerosis update

CE Markowitz - Am J Manag Care, 2013 - ajmc.s3.amazonaws.com
Multiple sclerosis (MS) is a chronic but incurable disease of the central nervous system
(CNS) that is often diagnosed in the second or third decade of life. It is more common among …

Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines

B Yamout, M Sahraian, S Bohlega, M Al-Jumah… - Multiple sclerosis and …, 2020 - Elsevier
With evolving diagnostic criteria and the advent of new oral and parenteral therapies for MS,
most current diagnostic and treatment algorithms need revision and updating. The diagnosis …

Established and novel disease‐modifying treatments in multiple sclerosis

AH Cross, RT Naismith - Journal of internal medicine, 2014 - Wiley Online Library
Multiple sclerosis (MS) is a presumed autoimmune disorder of the central nervous system,
resulting in inflammatory demyelination and axonal and neuronal injury. New diagnostic …

Treatment of multiple sclerosis—success from bench to bedside

M Tintore, A Vidal-Jordana… - Nature Reviews …, 2019 - nature.com
The modern era of multiple sclerosis (MS) treatment began 25 years ago, with the approval
of IFNβ and glatiramer acetate for the treatment of relapsing–remitting MS. Ten years later …

Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies

DM Wingerchuk, JL Carter - Mayo Clinic Proceedings, 2014 - Elsevier
Multiple sclerosis (MS) is a chronic inflammatory demyelinating central nervous system
disease that typically strikes young adults, especially women. The pathobiology of MS …

Multiple sclerosis: it's not the disease you thought it was

LA Rolak - Clinical Medicine & Research, 2003 - Marshfield Clinic
Multiple sclerosis (MS), the most common disabling neurologic disease of young people,
afflicts approximately a quarter of a million Americans. The symptoms of MS result from …

Disease-modifying treatment in progressive multiple sclerosis

JR Ciotti, AH Cross - Current treatment options in neurology, 2018 - Springer
Purpose of review Multiple sclerosis (MS) is an immune-mediated disorder that affects the
central nervous system (CNS), often first affecting people in early adulthood. Although most …

Multiple sclerosis: an immune or neurodegenerative disorder?

BD Trapp, KA Nave - Annu. Rev. Neurosci., 2008 - annualreviews.org
Multiple sclerosis (MS) is an inflammatory-mediated demyelinating disease of the human
central nervous system. The clinical disease course is variable, usually starts with reversible …

[HTML][HTML] Multiple sclerosis review

MM Goldenberg - Pharmacy and therapeutics, 2012 - ncbi.nlm.nih.gov
Multiple sclerosis (MS) is a chronic autoimmune, inflammatory neurological disease of the
central nervous system (CNS). 1, 2 MS attacks the myelinated axons in the CNS, destroying …